Indian Journal of Pharmacy and Pharmacology

Development and Validation of Lercanidipine Hydrochloride and Atenolol by Using RP-HPLC and UV Spectroscopy

Full Text PDF Share on Facebook Share on Twitter

Author Details: Priyadarshani S. Bansode, Mahendra Singh Ranawat, Ravindra Kamble, Chetan Singh Chauhan

Volume : 1

Issue : 1

Online ISSN : 2393-9087

Print ISSN : 2393-9079

Article First Page : 37

Article End Page : 41


 Lercanidipine hydrochloride (LCD), a dihydropyridine calcium channel blocker is used in the treatment of hypertension. Atenolol (ATN), a cardio selective β-blocker is used as   antihypertensive, antianginal and antiarrhythmic. The proposed method was development and validation of UV-Spectrophotometric and RP-HPLC for determination in bulk and tablet dosage form. In UV Spectroscopic method, LCD showed λmax at 237 nm in 50% v/v acetonitrile. The RP-HPLC analysis was performed by using a mobile phase of methanol: water (95:5 v/v), at a flow rate of 1.0 ml/min. By comparing validation results of both the methods, UV-spectrophotometric method is found to be simple, economical and rapid and RP-HPLC method were found to more precise, accurate, rugged and robust.